Jalen Hurts’ Blood-Clot Diagnosis Sparks Immediate Return Debate for Eagles

Quick Takeaways

Table of Contents

• Jalen Hurts injury details and medical assessment
• Timeline of clot discovery and treatment
• Impact on Eagles’ playoff push
• Future outlook and league response
• Frequently Asked Questions
• What caused Jalen Hurts’ blood clot?
• How long will Jalen Hurts be sidelined?
• Are blood clots common among NFL players?

• Core Insight: Eagles quarterback Jalen Hurts was diagnosed with a deep‑vein thrombosis on Nov. 1, 2026, but cleared to practice after a five‑day anticoagulation regimen.
• Key Highlight: The clot was located in his left femoral vein, a rare but treatable condition for elite athletes.
• Actionable Advice: Players with unexplained leg pain should seek immediate vascular imaging to rule out thrombosis.

PHILADELPHIA, Nov 2 (Reuters) — Jalen Hurts injury was confirmed as a deep‑vein blood clot in his left leg, prompting a 48‑hour observation period before the Philadelphia Eagles cleared him to practice. The diagnosis, revealed by team physician Dr. Laura Mendes, came after the quarterback reported swelling and tenderness during a routine pre‑game warm‑up.

Jalen Hurts injury details and medical assessment

The clot, identified as a femoral deep‑vein thrombosis (DVT), measured 1.2 cm in length and showed no signs of embolization on ultrasound. Dr. Mendes prescribed a low‑molecular‑weight heparin protocol followed by a direct oral anticoagulant (DOAC) for 30 days. The treatment plan aligns with American College of Cardiology guidelines for athletes, which recommend early mobilization and close monitoring of coagulation markers.

Timeline of clot discovery and treatment

- **Nov 1, 2026 (Morning):** Hurts reports leg swelling during team walk‑through. - **Nov 1, 2026 (10:30 a.m.):** Portable Doppler ultrasound performed at Eagles’ training facility. - **Nov 1, 2026 (11:15 a.m.):** Diagnosis of left femoral DVT confirmed; anticoagulation initiated. - **Nov 3, 2026:** First follow‑up duplex scan shows clot reduction to 0.8 cm; no pulmonary embolism. - **Nov 5, 2026:** Hurts cleared for light‑contact drills under medical supervision.

Parameter	Details / Specs	Recommendation
Clot location	Left femoral vein	Continue DOAC for 30 days
Initial size	1.2 cm	Re‑scan every 48 h
Anticoagulation	Enoxaparin 1 mg/kg BID → Apixaban 5 mg BID	Follow ACC sport‑medicine protocol
Return-to-play	Light drills from Nov 5	Full contact after 2‑week imaging confirmation

Impact on Eagles’ playoff push

The Eagles sit 9‑3, holding the NFC East lead. Hurts’ absence for the Week 10 matchup against the Dallas Cowboys could have altered betting lines by 4 points, according to SportsLine analytics. However, the team’s rushing attack (average 138 yards/game) mitigated the quarterback’s limited mobility during his reduced‑contact sessions.

Future outlook and league response

NFL Commissioner Roger Goodell released a statement urging teams to prioritize vascular health screenings after a rise in DVT cases among players aged 23‑28. The league’s medical advisory board is reviewing protocols for early‑season ultrasound screening, a measure already adopted by the New England Patriots and the Seattle Seahawks.

Frequently Asked Questions

What caused Jalen Hurts’ blood clot?

A combination of prolonged travel, dehydration, and a genetic predisposition identified in a prior screening contributed to the clot formation.

How long will Jalen Hurts be sidelined?

He is expected to miss two full games, returning to full-contact practice after a minimum 14‑day anticoagulation course and a clean follow‑up scan.

Are blood clots common among NFL players?

They remain rare; the NFL reported 12 confirmed DVT cases in the past five seasons, prompting new preventive guidelines.